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Abstract
Background: The mortality of severe malaria [cerebral malaria (CM), severe malaria anemia (SMA), acute lung injury (ALI) and
acute respiratory distress syndrome (ARDS)] remains high despite the availability associated with adequate treatments.
Recent studies in our laboratory and others have revealed a hitherto unknown correlation between chemokine CXCL10/
CXCR3, Heme/HO-1 and STAT3 and cerebral malaria severity and mortality. Although Heme/HO-1 and CXCL10/CXCR3
interactions are directly involved in the pathogenesis of CM and fatal disease, the mechanism dictating how Heme/HO-1
and CXCL10/CXCR3 are expressed and regulated under these conditions is still unknown. We therefore tested the
hypothesis that these factors share common signaling pathways and may be mutually regulated.
Methods: We first clarified the roles of Heme/HO-1, CXCL10/CXCR3 and STAT3 in CM pathogenesis utilizing a well
established experimental cerebral malaria mouse (ECM, P. berghei ANKA) model. Then, we further determined the
mechanisms how STAT3 regulates HO-1 and CXCL10 as well as mutual regulation among them in CRL-2581, a murine
endothelial cell line.
Results: The results demonstrate that (1) STAT3 is activated by P. berghei ANKA (PBA) infection in vivo and Heme in vitro. (2)
Heme up-regulates HO-1 and CXCL10 production through STAT3 pathway, and regulates CXCL10 at the transcriptional level
in vitro. (3) HO-1 transcription is positively regulated by CXCL10. (4) HO-1 regulates STAT3 signaling.
Conclusion: Our data indicate that Heme/HO-1, CXCL10/CXCR3 and STAT3 molecules as well as related signaling pathways
play very important roles in the pathogenesis of severe malaria. We conclude that these factors are mutually regulated and
provide new opportunities to develop potential novel therapeutic targets that could be used to supplement traditional
prophylactics and treatments for malaria and improve clinical outcomes while reducing malaria mortality. Our ultimate goal
is to develop novel therapies targeting Heme or CXCL10-related biological signaling molecules associated with
development of fatal malaria.
Citation: Liu M, Amodu AS, Pitts S, Patrickson J, Hibbert JM, et al. (2012) Heme Mediated STAT3 Activation in Severe Malaria. PLoS ONE 7(3): e34280. doi:10.1371/
journal.pone.0034280
Editor: Gordon Langsley, Institut National de la Sante ´ et de la Recherche Me ´dicale - Institut Cochin, France
Received August 4, 2011; Accepted February 25, 2012; Published March 30, 2012
Copyright:  2012 Liu et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by the National Institutes of Health grant numbers NIH/FIC T90-HG004151 for postdoctoral training in Genomics and
Hemoglobinopathies, NIH/FIC/NINDS R21TW006804, NIH/MBRS/SCORE S06GM08248 and NIH/RCMI RR033062 awarded to JKS and NIH/K02HL088026 awarded to
SFOA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: jstiles@msm.edu
Introduction
Malaria (Plasmodium. falciparum) infects 200 to 300 million people
globally and kills approximately 900,000 (mostly children) every
year. Current anti-malaria drugs, such as quinine and artemisinin
derivatives can effectively clear malaria parasites in blood,
however a significant numbers of severe malaria patients including
CM patients die or develop severe sequelae regardless of treatment
[1,2]. It is not clear which factors exacerbate mortality among this
subset of CM patients, therefore important questions remain to be
answered concerning the mechanism(s) of malaria pathogenesis
and development of effective therapies. Existing anti-malaria
therapy focus on clearance of parasites from blood. This strategy
does not prevent secondary deleterious effects such as neurological
disorders and cognitive problems caused by parasite derived
factors. Recent studies have demonstrated that many pathological
changes result from malaria-induced secondary effects which
involve various signaling molecules and pathways in the host,
indicating that malaria pathogenesis is highly complex and
multifactorial, [3,4,5].
Recently, it has been shown that increased level of free Heme
produced during malaria infection induces inflammation that
damages host vascular endothelium which is responsible for
induction of fatal cerebral pathogenesis as well as acute lung injury
(ALI)/ARDS [4,5,6,7]. Heme oxygenase (HO) is the rate-limiting
step enzyme in the degradation of Heme groups to biliverdin,
carbon monoxide (CO) and iron. Up-regulation of HO-1 protects
against cellular stress including oxidative stress, heavy metal
toxicity, UV radiation, and inflammation, thus preventing
deleterious effects of Heme and mediating anti-inflammatory
and anti-apoptotic functions [8,9]. HO-1 induced by reactive
oxygen species and nitric oxide (NO), has recently been shown to
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facilitate the repair of injured tissues through inhibition of
infiltrating inflammatory cells [12]. Severe malaria is associated
with perturbation of inflammatory cytokines, chemokines, anti-
inflammatory cytokines and angiopoietic factors [13]. Chemokine
CXCL10 is a cytokine belonging to the CXC chemokine family.
CXCL10 binds CXCR3 receptor to induce chemotaxis, apoptosis,
cell growth and angiostasis [14,15]. It is expressed early in mice
infected with P. berghei ANKA (ECM) as well as in human CM
[13,16]. Studies conducted in India and Ghana have identified
CXCL10 as a serological marker highly linked with increased risk
of fatal P. falciparum-mediated CM mortality in humans [3,17,18].
Following our report of a role of CXCL10 in fatal human CM,
several groups utilized gene knockout mice (CXCL102/2,
CXCR32/2, IFN-c2/2) in ECM to confirm and demonstrate
the role of CXCL10/CXCR3 interactions in the pathogenesis of
fatal CM via the recruitment and activation of pathogenic CD8+
T cells [19,20,21]. In fact, survival of mice infected with the lethal
strain of P. berghei ANKA CM [19] increased to 80% in
CXCL102/2 and CXCR32/2 mice when compared with the
wild type within the observation period of 10–12 days post
infection. In addition to genetic deletion of CXCL10 gene, Nie et
al [22] also reported that CXCL10 neutralization with specific
antibodies protected against cerebral malaria infection and
inflammation. Passive transfer of anti-CXCL10 antibodies re-
duced the recruitment of inflammatory leukocytes across the blood
brain barrier, while genetic deletion of CXCL10 not only
alleviated intravascular inflammation but also reduced pRBC
sequestration in the brain [22]. Not surprisingly, adoptive transfer
of CD8+ cells abrogated protection of CM in CXCR32/2 mice
[21]. In addition, NK cells mediate direct cytotoxic activity or
reconstitution of capacity of T cells to migrate in response to
CXCL10 to the central nervous system (CNS) in CM [23,24].
Thus, the relationship between over production of Heme,
CXCL10/CXCR3, and related signaling mechanisms and fatal
CM needs clarification.
The signal transducer and activator of transcription (STAT3) is
a signaling molecule which can be activated by pro- and ant-
inflammatory stimuli and cellular stresses, therefore STAT3 can
be either pro-inflammatory and anti-inflammatory [25]. Many
cytokines can activate STAT3, for instance, STAT3 is essential for
the function of both interleukin-6 (IL-6) and IL-10, whereas IL-6 is
a proinflammatory cytokine, IL-10 is an anti-inflammatory
cytokine [26,27]. Among the cytokines activating STAT3, only
IL-10 activates the anti-inflammatory pathway that is STAT3-
dependent [28]. Opposing roles of IL-6 and IL-10 mediated by
STAT3 might be explained by selective blocking IL-6 and IL-10
signaling by suppressor of cytokine signaling (SOCS3) recruitment,
which is part of the STAT3 negative-feedback loop. SOCS3 is a
relatively specific inhibitor of gp130 [29], and is a key regulator of
IL-6 and IL-10 [26]. SOCS3 selectively blocks signaling by IL-6,
specifically prevents activation of STAT3 by IL-6 but not IL-10
[29], thereby preventing its ability to inhibit lipopolysaccharide
(LPS)-induced anti-inflammatory signaling. Thus in the absence of
SOCS3 in macrophages, the action of IL-6 shifted from inducing a
pro-inflammatory responses to a STAT3-mediated anti-inflam-
matory response [26]. STAT3 protein locates in the cytoplasm in
an inactive form and is activated via phosphorylation (pSTAT3)
by the Janus tyrosine kinases (JAKs). Although it is known that the
proinflammaotry NF-kB pathway [30,31], Src family kinase
[32,33] and Rho kinase [2] modulate host response to P.
falciparum, little is known about the role of STAT3 in Plasmodium
strain infection. The reason that we are interested in STAT3
molecule is that both STAT3 and NF-kB are active during
inflammation, the STAT3/NF-kB overlapping sites can be found
in the regulatory region of several genes [34]. These transcription
factors are suggested to regulate each others’ function through
competition for overlapping DNA binding sites [34]. Since NF-kB
is a well established signaling pathway which contributes to the
initiation and development of malaria, we hypothesize that
STAT3 may plays an important role in the pathogenesis of severe
malaria.
To understand how Heme/HO-1, CXCL10/CXCR3 and
STAT3 are involved in the pathogenesis of CM [3,4,5], as well as
which tissues are involved in the Heme/HO-1 or CXCL10/
CXCR3 or STAT3 pathways, and how their expression are
regulated in malaria, we conducted a study focus on clarifying the
roles of Heme/HO-1, CXCL10/CXCR3 and STAT3 in CM
pathogenesis utilizing a well established experimental cerebral
malaria (ECM) model, validating results in appropriate in vitro
methods. We believe that our study will provide a basis for
development of novel therapies targeting biological signaling
molecules associated with development of fatal malaria. The
potential novel therapeutic targets identified in this study will
supplement traditional prophylactics and treatments for malaria
and improve clinical outcomes while reducing malaria mortality.
Results
Infection of C57BL/6 with P.berghei ANKA causes brain,
lung and kidney damage
C57BL/6 mice were intraperitoneally inoculated with 1610
6
P.berghei parasitized RBC (pRBC), an inoculum which leads to
cerebral malaria in the majority of infected mice. During infection,
parasitemia and anemia status were monitored through mice tail
blood analysis daily for eight consecutive days. P.berghei parasit-
emias was observed in both wild type (WT) and CXCL102/2
mice although below 15% in CXCL102/2 mice (Figure 1A).
Hemoglobin (Hb) levels was lower in infected wild type mice when
compared to CXCL102/2 mice as shown in Figure 1B. CXCL10
gene deficient mice had no significant decrease in Hb levels as seen
in WT. There was no significant difference in the number of
parasitized RBC (arrow) in blood smears of WT (Figure 1C) and
CXCL102/2 mice (Figure 1D) infected with P. berghei (PBA).
Figure 1C also showed that similar maturation stages of the
parasite was observed to circulate in WT and CXCL102/2 mice.
Although P.berghei ANKA infected CXCL102/2 mice have
reduced mortality [19] but have similar level of parasitemia as
control mice.
C57BL/6 mice infected with P.berghei ANKA is a well accepted
murine model of experimental cerebral malaria (ECM) and has
been used as a useful surrogate of human CM [4]. This model has
been criticized by some researchers [35]. They stated that unlike
the pulmonary pathology observed in the murine model by which
pRBC sequestration is similar to that observed in human post
mortem tissues, encephalopathy in murine model is characterized
by monocyte sequestration [35]. However a recent study reported
by Baptista et al [36] found that ECM model shares some
characteristics of human CM such as intracerebral accumulation
of parasitized RBC, which is crucial for the onset of CM
pathology. Whether these pRBC are sequestered to host
endothelium or not need to be further investigated. Brain
histopathological examination showed that infection of C57BL/6
with P.berghei caused brain damage. Compared to non-infected
controls (Figure 1E, ‘‘C’’ means non-infected control), brains of
ECM animals showed significant disruption of vascular endothelial
wall, with degeneration and cerebral edema as indicated by
enlargement of perivascular spaces (Figure 1F, ‘‘In’’ means PBA
STAT3 Activation in Severe Malaria
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(Figure 1G, yellow arrows) were common in white and grey
matters in ECM mice. Adherence of pRBC and leucocytes to
brain vessels and vascular plugging were present in all sections of
ECM mice analyzed (Figure 1H, black arrow). Histopathological
examination also showed necrotic tissues in grey matter in PBA-
infected C57BL/6 mice (Figure 1H, yellow arrow head). No
histological lesions were detected in non-infected controls of brain
tissues (Figure 1E). No obvious pathological lesions were detected
in CXCL10 gene deficient mice (CXCL102/2) infected with PBA
(Figure 1J) compared to corresponding controls (Figure 1I).
The lung tissues in C57BL/6 mice after the onset of ECM were
characterized by a discrete presence of leucocytes and alveolar
edema without marked thickening of the alveolar septum by HE
staining (Figure 1L) compared to normal control (Figure 1K). No
obvious pathological lesions were detected in CXCL102/2 mice
infected with PBA (Figure 1N) as well as non-infected controls
(Figure 1M). Apoptotic cells were recognized by a TUNEL assay
(Figure 1T, in red) in the lung tissue of WT mice. To determine
whether the apoptotic cells are endothelial cells, staining with the
endothelial specific anti-vWF antibody (green) was used. The low-
power images (Figure 1S) show strong vWF immunoreactivity in
Figure 1. Infection of C57BL/6 with P.berghei ANKA causes brain, lung and kidney damage. 1) C57BL/6 mice were intraperitoneally
inoculated with 1610
6 P.berghei parasitized RBC (pRBC or iRBC) (C=non-infected control, In=infected with PBA), parasitemia and Hb were monitored
through mice tail blood samples daily. A: parasitemias in both WT and CXCL102/2 mice were below 15% after infection with PBA for 8 days. B: Hb
levels were lower in infected WT mice compared to non-infected controls. Hb levels in CXCL102/2 mice were similar to corresponding non-infected
controls. C: blood smear of infected WT mice with arrow showing parasitized RBC. D: blood smear of infected CXCL102/2 mice with arrow showing
parasitized RBC. 2) Paraffin-embedded sections of brain tissues were stained with Hematoxylin-Eosin (HE) (magnification of all panels of Figure 1 is
2006 with some exceptions where the magnifications are specifically indicated). Brains of ECM animals showed disruption of vessel walls with
endothelial degeneration and cerebral edema as indicated by enlargement of perivascular spaces (Figure 1F). In addition, parenchymal
microhaemorrhages (Figure 1G, yellow arrows) were common in white and grey matters in ECM mice. Adherence of pRBC and leucocytes to brain
vessels and vascular plugging were present in all sections of ECM mice analysed (Figure 1H, black arrow). Histopathological examination also showed
necrotic findings in grey matter in PBA-infected C57BL/6 mice (Figure 1H, yellow arrow head). No histological lesions were detected in non-infected
controls of brain tissues (Figure 1E). No obvious pathological lesions were detected in CXCL10 gene deficient mice (CXCL102/2) infected with PBA
(Figure 1J) compared to corresponding controls (Figure 1I). 3) In the lung of C57BL/6 mice the onset of ECM was characterized by the presence of
leucocyte infiltrates and alveolar edema without marked thickening of the alveolar septum by HE staining (Figure 1L) compared to normal control
(Figure 1K). 1M and 1N showed HE staining in lung of CXCL102/2 mice without and with PBA infection. Apoptotic cells were revealed by TUNEL
assay (Figure 1T, in red). The low-power images (Figure 1S) show strong vWF immunoreactivity in pulmonary tissues and blood vessels. Co-
localization of vWF-positive and TUNEL-positive cells (Figure 1U) in lung confirmed the presence of apoptotic pulmonary endothelial cells. Figure 1V,
1W and 1X showed no apoptotic pulmonary endothelial cells in non-infected control animals. Kidney histopathology revealed that infection of
C57BL/6 with P.berghei caused proximal convoluted tubular cell swelling and denaturation. The onset of ECM was characterized by proximal
convoluted tubular cell swelling and eosinophilic denaturation as well as narrowed space between tubules (Figure 1P) compared to non-infected
control (1O). ). 1Q and 1R showed HE staining in kidney of CXCL102/2 mice without and with PBA infection.
doi:10.1371/journal.pone.0034280.g001
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positive and TUNEL-positive cells (Figure 1U) in lung tissues
confirm the presence of apoptotic pulmonary endothelial cells.
Figure 1V, 1W and 1X showed no apoptotic pulmonary
endothelial cells in non-infected control animals.
Kidney histopathological examination indicated that infection
of C57BL/6 with P.berghei caused proximal convoluted tubular cell
swelling and denaturation. The kidney tissues in C57BL/6 after
the onset of ECM were characterized by proximal convoluted
tubular cell swelling and eosinophilic denaturation as well as
narrowed spaces between tubules (Figure 1P) compared to non-
infection control (1O). No obvious pathological lesions were
detected in CXCL102/2 mice infected with PBA (Figure 1R) as
well as non-infected controls (Figure 1Q). No apoptotic cells were
observed in the glomeruli and tubules (data not shown).
Heme/HO-1, CXCL10 and STAT3 are involved in P. berghei
ANKA infected ECM
Plasma levels of Heme and HO-1 are increased in P.
berghei ANKA infected ECM mice. Plasma levels of Heme
significantly increased in infected wild type (WT) C57 BL/6 mice
than those of non-infected controls, indicating that plasma Heme
is associated with PBA infection in mice (Figure 2, left panel).
Additionally, HO-1 plasma levels were significantly higher in the
infected wild type C57 BL/6 mice compared to the control mice,
suggesting HO-1 could be a protective factor against Heme
(Figure 2, right panel). CXCL102/2 infected mice showed the
same pattern as CXCL102/2 non-infected mice regarding
plasma concentration of Heme and HO-1. When infected with
PBA, CXCL102/2 mice do not present the same increase in the
levels of Heme or HO-1 as WT mice do during infection (Figure 2).
High expression levels of HO-1 and tyrosine-
phosphorylated STAT3 (pSTAT3) occur in kidney, brain
and lung tissues of mice infected with P. berghei
ANKA. Figure 3 shows the mean ratio of HO-1 mRNA
expression to GAPDH expression in mice (n=6) on day 2, 4
and 8 respectively. Infection of C57BL/6 WT or CXCL102/2
mice with P. berghei (C=non-infected control, In=infected with
PBA) up-regulated HO-1mRNA in the kidney (A), brain (B) and
lung (C), suggesting HO-1 expression may be protective against P.
berghei induced damage in these organs. Mice deficient in CXCL10
down-regulated HO-1 in both uninfected and infected groups
(white vs. red; black vs. yellow), suggesting that transcription of
mouse HO-1 gene is positively regulated by CXCL10. HO-1 and
the active STAT3 molecules-pSTAT3
Tyr705 protein were also
examined in kidney (Figure 4A), brain (Figure 4B) and lung
(Figure 4C) by Western blot. Corresponding densitometric analysis
of the bands performed with the ImageQuant program (Bio-Rad)
were shown below the Western blot. The data demontrated that P.
berghei infection up-regulates HO-1 and pSTAT3 protein in
various tissues of WT mice. pSTAT3 levels peaked on day 2 in
kidney and lung and on day 4 in brain but appeared earlier than
those of HO-1 which peaked on day 4 in kidney and lung and on
day 8 in brain respectively. However, P. berghei infection failed to
up-regulate HO-1 protein in CXCL102/2 mice (Figure 4D–F).
HO-1 protein was mostly located in the nucleus as shown by
immunohistochemistry (IHC) analysis (Figure 5) [C=non-infected
controsl, In=infected with PBA]. Consistent with the levels of
mRNA detected by real-time reverse transcription polymerase
chain reaction (qRT-PCR) assay as shown in Figure 3 and protein
levels detected by Western blot as shown in Figure 4, HO-1 levels
were significantly increased in PBA infected WT of C57 BL/6
mice (Figure 5B vs.5A, 5F vs.5E, 5G vs. 5I), but no signicicant
difference of HO-1 expression between non-infected and infected
group in CXCL10 gene deficient mice (Figure 5D vs. 5C, 5H
vs.5G, 5L vs.5K) were found.
High levels of CXCL10 is associated with ECM onset in
C57BL/6 mice infected with P. berghei ANKA. Levels of
CXCL10 mRNA (Figure 6, left panel) were much higher in
kidney, brain and lung tissues in infected than uninfected mice on
day 4 and day 8 respectively. The similar results were further
confirmed by immunohistochemistry analysis as shown in the right
panel of Figure 6. The membrane and cytoplasma staining of
CXCL10 protein were much stronger in the kidney, brain and
lung of PBA infected WT C57 BL/6 mice compared to
corresponding controls (Figure 6B vs. 6A, 6D vs. 6C, 6F vs.6E).
These data indicate that fatal ECM is associated with high levels of
CXCL10 expression in vital organs in C57BL/6 WT mice.
Heme mediated STAT3 activation in vitro
HO-1 and CXCL10 are induced by Heme and its synthetic
inducer in mouse endothelial CRL2581 cell line. In cerebral
Figure 2. Plasma levels of Heme and HO-1 are increased in ECM mice infected with P. berghei ANKA. In left panel of Figure 2, plasma
levels of Heme were significantly increased in PBA-infected wild type C57 BL/6 mice (n=6) than those of non-infected controls (n=6), indicating that
plasma Heme was associated with PBA infection in mice. HO-1 plasma levels were significantly higher in the PBA-infected wild type C57 BL/6 mice
compared to controls, suggesting HO-1 may be a protective factor against Heme (right panel). CXCL102/2 infected mice showed the same pattern
as CXCL102/2 non-infected mice regarding plasma concentration of Heme and HO-1. When infected with PBA, CXCL102/2 mice do not present the
same increase in the levels of Heme or HO-1 as WT mice do during infection (Figure 2). Data are shown as mean 6 SD (n=6 per group).
doi:10.1371/journal.pone.0034280.g002
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produced that induces inflammation that results in damage to host
microvascular endothelium. Our studies indicated that
transcription of mouse HO-1 gene is positively regulated by
CXCL10 (Figure 3). STAT3 protein was activated in mice infected
with PBA (Figure 4). To determine how Heme, HO-1 and
CXCL10 signaling pathways were regulated as well as how
STAT3 pathway was associated with these two signaling
molecules, mouse endothelial cell line CRL-2581 was treated in
vitro with Heme to investigate the regulatory mechanism
controlling Heme/HO-1, CXCL10 and STAT3 function. The
results show that expression of HO-1 mRNA (Figure 7A) and
protein (Figure 7B) are significantly up-regulated by Heme and the
HO-1 enzymatic inducer-CoPP. HO-1 expression peaked at 5–
10 mM for Heme and 5–15 mM for CoPP. HO-1 mRNA
(Figure 7C) and protein (Figure 7D) were down-regulated by
HO-1 inhibitor ZnPP. The expression of CXCL10 mRNA
(Figure 7E) was also significantly up-regulated by Heme and
CoPP treatment. The CXCL10 promoter activity was
proportional to amounts of CXCL10 luc (Figure 7F) within the
100 ng to 1000 ng range when treated with Heme. Figure 7G
shows that Heme enhances the CXCL10 promoter activity in a
dose-dependent manner within a 1 mMt o5mM range.
STAT3 activation is induced by Heme. Decreased
activation of STAT3 by siRNA-STAT3 (siSTAT3) and AG490
down regulates HO-1 and CXCL10 protein. Recently Chen’s
group [37] found that the lethal strain of P. yoelli (XL) caused
STAT3 activation which inhibited host protective immunity and
resulted in high parasitemia and death. To analyze the
involvement of STAT3 during the course of P. berghei ANKA
infection, a process which produces significant amount of free
Heme [4], we assessed the expression levels of total STAT3
(tSTAT3) and pSTAT3 in CRL-2581 cells. pSTAT3 was
increased by Heme concentrations from 1 mMt o5 mM and
then decreased (Figure 8A). When pSTAT3 is reduced by
siSTAT3 (Figure 8B) or by a pharmacological inhibitor of Jak,
AG490 (Figure 8C), HO-1 protein expression was inhibited.
Reduced activation of STAT3 caused by siSTAT3 (Figure 8D)
and AG490 (Figure 8E) also caused reduced expression of
CXCL10. These data indicate that Heme induces the
production of HO-1 or CXCL10 via a STAT3 signaling
pathway. We futher found when CXCL10 was blocked by anti-
CXCL10 antibody, HO-1 induction by Heme was decreased to
one half, indicating that CXCL10 directly induce HO-1
expression (Figure 8F). Reduced HO-1 expression by siHO-1
increased CXCL10 expression which implies that HO-1 also
modulates CXCL10 expression (Figure 8G). Interestingly,
pSTAT3 level was increased by CoPP and decreased by ZnPP
(Figure 8H), which indicates that HO-1 also regulates STAT3
signaling. None of the treatment had effects on tSTAT3. Based on
our findings, a schematic model for the regulation of Heme/HO-
1, CXCL10 and STAT3 was shown in Figure 9.
Discussion
Severe malaria pathogenesis is associated with dysfunction of
multiple organs [38]. The fatal cases are composed of cerebral
malaria (CM) and other severe forms of malaria such as severe
malaria anemia (SMA). Accumulating evidence indicates that
acute lung injury (ALI)/ ARDS caused by malaria is responsible
for significant proportion of the mortalities in children and
pregnant woman [6,39]. Additionally, acute renal failure is a
complication of Plasmodium infection in non-immune and semi-
immune African children which often results in mortalities [40,41].
However, the precise mechanism(s) responsible for fatal CM-
induced brain damage and malaria-induced pulmonary disruption
are unclear. Two main hypotheses have been proposed for human
CM. The first is the mechanical hypothesis, which proposes that
infected Red Blood Cells (iRBC or pRBC) binding to endothelial
cells (EC), obstruct blood flow in micro capillaries leading to low
tissue perfusion, compromised oxygenation and tissue damage.
The second is the immunopathological hypothesis which proposes
that host hyper-inflammatory responses to parasite infections
responsible for eliminating P. falciparum parasites cause edema,
dysfunction in blood brain barrier (BBB), organ failure and death.
Figure 3. Hmox1(HO-1) messenger RNA (mRNA) expression in kidney, brain, and lung as determined by quantitative RT-PCR. Data
are shown as mean 6 SD (n=6 per group). *P,0.05; ** P,0.01. mRNA expression of HO-1 in kidney, brain and lung tissues of mice infected with P.
berghei ANKA are increased significantly. The data showed the mean ratio of HO-1 mRNA expression to GAPDH expression (n=6) in mice on day 2, 4
and 8 respectively. Infection of C57BL/6 WT or CXCL102/2 mice with P. berghei (C=non-infected control In=PBA infectetion) up-regulated HO-1
mRNA in kidney (A), brain (B) and lung (C), suggesting HO-1 expression may be protective against P. berghei induced damage. Mice deficient in
CXCL10 down regulated HO-1 in both uninfected and infected C57BL/6 mice (white vs. red; black vs. yellow), suggesting that transcription of mouse
HO-1 gene is positively regulated by CXCL10.
doi:10.1371/journal.pone.0034280.g003
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various signaling molecules of the host is unkown. Our current
study has demonstrated that (1) infection of C57 BL/6 with
P.berghei ANKA (PBA) causes significant tissue damage, (2) Heme/
HO-1 and CXCL10 are involved in the pathogenesis of CM and
that the level of free Heme correlates with PBA infection in mice,
(3) Expression of HO-1 in tissues may be protective against Heme
and PBA induced damage, (4) High levels of CXCL10 is
associated with ECM onset in PBA infected mice, (5) STAT3 is
activated by PBA infection in vivo and Heme in vitro, (6) Heme up-
regulates HO-1 and CXCL10 production trough STAT3
pathway, and regulates CXCL10 at the transcriptional level in
vitro, (7) HO-1 transcription is positively regulated by CXCL10, (8)
HO-1 regulates STAT3 signaling. Taken together, our data
indicate that Heme/HO-1, CXCL10/CXCR3 and STAT3
molecules as well as related signaling pathways play very
important roles in inflammation and organ damage in the
pathogenesis of severe malaria.
Heme and HO-1 interaction moved center stage in cerebral
malaria research in 2007, when Mota’s group reported that HO-1
and carbon monoxide (CO) suppress the pathogenesis of ECM [4].
HO-1 was then found to be capable of inhibiting vascular occlusion
in transgenic sickle cell mice (sickle cell disease is a hemolytic
disease) [42,43]. From these studies it seems that the ability of
individuals to respond to increase in Heme by producing HO-1
may be a crucial endogenous protective factor. However, some
other studies have refuted the findings that HO-1 protects the
development of CM [44]. These studies suggests that the frequency
of short (GT)n alleles (,28 repeats), which may lead to high level of
HO-1, is markedly higher in CM patients [44]. Moreover, liver
stages of the Plasmodium was markedly reduced in Hmox12/2 mice
[4]. These conflicting results suggest that the regulated expression
of HO-1 is quite complex in different tissues at different stages of
the Plasmodium life cycle. Therefore, further experimental and
epidemiological studies are necessary to unveil the role of Heme
and HO-1 interactions in severity of malaria. HO-1 is a heat shock
protein (hsp32), which is an integral membrane protein of the
smooth endoplasmic reticulum [45], and is the only inducible
isoform of HO. The expression of HO-1 occurs at low levels in
most tissues under physiological conditions [40]. HO-1 can localize
Figure 4. High expression level of HO-1 protein and phosphorylated STAT3 (pSTAT3) occur in kidney, brain and lung tissues of
mice infected with P. berghei ANKA (n=6 per group). HO-1 and the active STAT3 molecules-pSTAT3
Tyr705 protein were examined in kidney
(Fig. 4A), brain (Fig. 4B) and lung (Fig. 4C) of some mice by Western blot. P. berghei infection up-regulates HO-1, pSTAT3 protein in various tissues of
C57BL/6 mice. pSTAT3 level peaked on day 2 in kidney and lung and on day 4 in brain, STAT3 level appeared earlier than those of HO-1, which
peaking on day 4 in kidney and lung, on day 8 in brain respectively. However, P. berghei infection failed to up-regulate HO-1 protein in CXCL102/2
mice (Figure 4D–F). Corresponding densitometric analysis of the bands performed with the ImageQuant program were shown below the Western
blot. Data are shown as mean 6 SD (n=6 per group). *P,0.05; ** P,0.01.
doi:10.1371/journal.pone.0034280.g004
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appeared in plasma membrane, cytosol, mitochondria [46],
isolated caveolae and nucleus [47] in cell culture models. Early
studies indicate that HO-1 in mitochondria and caveolae performs
important biological and physiological actions [46], although the
function of HO-1 in caveolae and nucleus is not completely
Figure 5. HO-1 protein locates in the nucleus. Tissue sections were deparaffinized followed by rehydration in a standard manner. Specific
primary antibody against HO-1 were added at 1:200 dilution overnight. The activated HO-1 protein was located in the nucleus as showed by the
immunohistochemistry assay. HO-1 levels were significantly increased in PBA infected WT of C57 BL/6 mice (Figure 5B vs.5A, 5F vs.5E, 5G vs. 5I), but
no significant difference between non-infected and infected group in CXCL10 gene deficient mice (Figure 5D vs. 5C, 5H vs.5G, 5L vs.5K) was found.
doi:10.1371/journal.pone.0034280.g005
Figure 6. ECM is associated with high levels of CXCL10 expression in vital organs in C57BL/6 WT mice. Left panel: CXCL10 messenger
RNA (mRNA) expression in kidney, brain, and lung as determined by quantitative RT-PCR. Data are shown as mean 6 SD (n=6 per group). *P,0.05;
** P,0.01. ECM onset in C57BL/6 mice infected with P. berghei ANKA reveals that levels of CXCL10 mRNA were much higher in kidney, brain and lung
tissues in infected than uninfected mice on day 4 and day 8 respectively (left panel). Right panel (Figure 6A–6F): representative examples of HO-1
immunohistochemistry staining in kidney, brain and lung of C57BL/6 wild type mice. Membrane and cytoplasma staining of CXCL10 protein were
much stronger in the kidney, brain and lung of PBA infected WT C57 BL/6 mice compared to corresponding controls (Figure 6B vs. 6A, 6D vs. 6C, 6F
vs.6E).
doi:10.1371/journal.pone.0034280.g006
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transcriptional regulator [46]. Under conditions of hypoxia, hemin
or Heme-hemopexin, HO-1 translocates to the nucleus. Nuclear
translocation compromises the HO activity, but nuclear localiza-
tion of HO-1 protein functions to up-regulate genes that promote
cytoprotection against oxidative stress [45]. Our data showed that
levels of HO-1 were significantly increased in plasma and tissues
(both mRNA and protein), the activated HO-1 protein was mostly
located in the nucleus, which supports the hypothesis that HO-1
protects against Heme and tissue damage. In CXCL102/2 mice,
PBA infection caused modest increase in HO-1 mRNA (Figure 3),
but not in HO-1 protein [(neither in plasma (Figure 2) nor tissue
(Figure 4)], there could be a number of reasons. HO-1 protein may
be expressed but at levels below detectable limits, or may be rapidly
degraded. As protein expression reflects functional adaption
observed in species phenotype [48], HO-1 in either case probably
did not exert the expected protection. Considering the fact that
there was no significant difference in free Heme level between
CXC102/2 infected mice and non-infected controls (Figure 2), we
postulated that HO-1 activation may not be required under this
situation.
Animal models provide valuable biological information under
controlled circumstances. However, different mice strains show
variations in susceptibility to rodent malaria [49,50], this may
reflect qualitative or quantitative differences in host immune
response to the parasite and differences in the pathogenicity of
sub-strains of murine malaria parasite species. C57BL/6 infected
with PBA shares many features similar to human CM. However,
lung damage might not be severe enough to cause animal death
[6]. This may explain why the pathological manifestation in lung
and kidney was modest our study.
Our observation of Hb levels being lower in infected wild type
mice is consistent with previous studies which showed that P.berghei
ANKA infection in C57BL/6 results in anemia. CXCL10 gene
deficiency prevents decrease in Hb levels (Figure 2). Since the level
of free Heme is not increased (Figure 2), it is possible that this may
occur through reduction of hemolysis of infected RBC. But the
compromised clearance of uninfected RBCs or erythroid response
could not be excluded as a possibility [51,52,53].
A recent study in Ghanaian patients demonstrated an
association between fatal CM and increased serum and cerebro-
spinal fluid (CSF) levels of proinflammatory and proapoptotic
factors including CXCL10, IL-1ra, sTNFR1, sTNFR2 and sFas
and decreased serum and CSF levels of neuroprotective
angiogenic growth factors (PDGFb) [3]. Further investigation in
Indian patients confirmed findings from Ghana, thus indicating
Figure 7. HO-1 and CXCL10 are induced by Heme and its synthetic inducer in mouse endothelial CRL2581 cell line. We exposed
mouse brain endothelial cell line CRL-2581 in vitro with Heme at different concentration. The results show that expression of HO-1 mRNA (A) and
protein (B) are significantly up-regulated by Heme and HO-1 enzymatic inducer-CoPP treatment. HO-1 expression peaked at 5–10 mM for Heme and
5–15 mM for CoPP. HO-1 mRNA (C) and protein (D) were down-regulated by HO-1 enzymatic activity inhibitor-ZnPP. The expression of CXCL10 mRNA
(E) were also significantly up-regulated by Heme and CoPP treatment. The CXCL10 promoter activity is proportional to amounts of CXCL10 luc (F)
within the range between 100 ng to 1000 ng when treated with Heme. Figure 7G showed that Heme enhanced the CXCL10 promoter activity in a
dose-dependent matter within the range from 1 mMt o5mM. Data are shown as mean 6 SD. *P,0.05; ** P,0.01.
doi:10.1371/journal.pone.0034280.g007
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angiogenic and anti-apoptotic factors, VEGF is negatively
correlated with mortality associated with CM [17]. Studies from
a murine CM model also confirmed importance of CXCL10/
CXCR3 interactions in the pathogenesis of fatal CM through the
recruitment and activation of pathogenic CD8+ T cells [20,54].
CXCL102/2 and CXCR32/2 mice are partially resistant to P.
berghei-mediated CM [19]. The animal studies demonstrate that
high level of CXCL10 in tissues is associated with ECM in PBA
infected mice, which is consistent with previous reports relating to
human studies. Our studies to determine the mechanisms by
which CXCL10 is up-regulated using in vitro cell culture models
revealed that Heme regulates CXCL10 at the transcriptional level
in vitro.
Our results also suggest that CXCL10 is positively associated
with HO-1 gene expression, and may be involved in the regulation
of HO-1 (Fig. 3 and Fig. 8F). Interestingly, an emerging body of
evidence demonstrates that HO-1 gene also regulates CXCL10
Figure 8. STAT3 activation is induced by Heme in CRL-2581 cells. Decreased activation of STAT3 by siRNA-STAT3 (siSTAT3) and AG490 down
regulates HO-1 and CXCL10 protein. pSTAT3 was increased by Heme from 1 mM and peaked at 5 mM and then decreased (A). When pSTAT3 was
reduced by siSTAT3 (B) or pharmacological inhibitor of Jak, AG490 (C), HO-1 protein expression was inhibited correspondingly. These data indicated
that Heme induced production of HO-1 by way of STAT3 signaling pathway. Reduced activation of STAT3 caused by siSTAT3 (Figure 8D) and AG490
(Figure 8E) also caused reduced expression of CXCL10. We futher found when CXCL10 was blocked by anti-CXCL10 antibody, HO-1 induction by
Heme was decreased to one half, indicating that CXCL10 directly induce HO-1 expression (Figure 8F). Reduced HO-1 expression by siHO-1 increased
CXCL10 expression which implies that HO-1 also modulates CXCL10 expression (Figure 8G). Interestingly, pSTAT3 level was increased by CoPP and
decreased by ZnPP (Figure 8H), which indicates that HO-1 also regulates STAT3 signaling.
doi:10.1371/journal.pone.0034280.g008
Figure 9. Schematic model for the regulation of Heme/HO-1, CXCL10 and STAT3. 1) Heme induced HO-1 and CXCL10 production, 2) Heme
induced HO-1 and CXCL10 expression through STAT3 activation, 3) A mutual signaling regulation loop exists between HO-1 and CXCL10.
doi:10.1371/journal.pone.0034280.g009
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mediated by suppression of CXCL10 during liver ischemia and
reperfusion injury [55,56,57] and kidney transplantation [58]. Our
results indicating that reduced HO-1 expression by siHO-1
increased CXCL10 expression (Figure 8G) support these previous
findings. Additionally, HO-1 may enforce angiostatic action via
CXCL10 during renal injury [12]. This observation supports the
views that a mutual signaling regulation loop exists between HO-1
and CXCL10. Detailed understanding of the characteristic
signaling abnormalities could contribute to novel approaches in
diagnosis and treatment of severe malaria.
STAT3 can be activated by pro- and ant-inflammatory stimuli
and cellular stresses, therefore STAT3 can be either pro-
inflammatory and anti-inflammatory [25] depending on the
recruitment of SOCS3, which is part of the STAT3 negative-
feedback loop. In the absence of SOCS3 in macrophages, the
action of a STAT3-mediated IL-6 shifted from inducing a pro-
inflammatory responses to an anti-inflammatory response [26].
The active form of STAT3 is quickly translocated to the host cell
nucleus. pSTAT3 was reported to be a potent negative modulator
of the Th1-mediated inflammatory response. It is also an activator
of a variety of genes which are important for immune modulation
[59,60]. Chen’s group reported that lethal Plasmodium yoelii (P.yoelii,
XL) induced activation of STAT3 in the early phase of infection,
the dominant pSTAT3 response may dampen the development of
protective immunity which results in high parasitemia and death
[37]. In the present study, we determined that STAT3 is activated
during PBA infection in vivo and Heme in vitro. Heme activated
STAT3 works as a pro- inflammatory factor. Heme induced up-
regulation of HO-1 and CXCL10 is through the STAT3 pathway.
Our results also indicate that the activation of STAT3 precedes
the peak levels of HO-1 induced by PBA infection, which is
consistent with previous report [37]. Interestingly our results also
show that HO-1 regulates STAT3 signaling in cell culture model.
The Heme/HO-1, CXCL10 and STAT3-related signaling
involved in CM pathogenesis are highly complex. Thus, a full
understanding of the interactions of these pathways will facilitate
the development of novel strategies for intervention against
malaria.
The mortality associated with severe malaria (CM, SMA and
ALI/ARDS) remains high in spite of availability of adequate
treatment [61]. Most adjunct treatments have failed to improve
the outcome of severe malaria since these treatments focus mainly
on the clearance of parasites. Recent studies have demonstrated
that many severe pathological changes result from malaria
induced secondary effects involving signaling molecules of the
host [3,4,5]. The signaling pathways activated by Plasmodium
infection and cross talks between them are still poorly understood
and definitely represent a fruitful area for further study.
Methods
Ethics statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The
protocol was approved by the Institutional Animal Care and
Usage Committee (IACUC) of Morehouse School of Medicine
(Permit Number 09-06).
Mice
6–8-week-old female C57BL/6 and C57BL/6 CXCL102/2
mice (The Jackson Laboratory, Bar Harbor, Maine) were used as a
CM strain for the experiments. The mice were housed under
standard conditions in the animal facility of Morehouse School of
Medicine (MSM) and supplied with food and water ad libitum. The
animals were allowed to adjust to their new environment for at
least 3 days before the testing. Mice were infected intraperitoneally
with 1610
6 P.berghei parasitised erythrocytes (pRBC) in 0.2 ml
phosphate buffered saline (PBS), which were obtained from whole
blood of a mouse infected with frozen stocks of PBA [62].
Non-infected C57BL/6 and C57BL/6 CXCL102/2 mice
injected with normal RBC served as control groups. Mice were
sacrificed at days 2, 4 and 8 to harvest brain, kidney and lung for
analysis of different purposes. All animal studies conformed to
national regulations on animal experimentation and welfare, and
the Care of Laboratory Animal Resources (CLAR) guidelines for
the care and use of laboratory animals.
Cell culture
CRL-2581, a murine endothelial cell line obtained from
American Type Culture Collection (Manassas, VA), were
maintained and grown in DMEM medium with 10% heat-
inactivated fetal bovine serum (FBS) (Life Technologies, Inc.), and
penicillin/streptomycin (Hyclone). Cells were maintained at 37uC
under 5% CO2.
Antibodies and reagents
Polyclonal antibody against HO-1 was obtained from Assay
Designs (Ann Arbor, MI). STAT3 and phospho-STAT3 were
purchasedfromCellSignalingTechnology.Antibodytob-actinwas
obtained from Sigma-Aldrich. Polyclonal anti-vWF antibody was
purchased from DAKO (Carpinteria, CA). Anti-mouse CXCL10
antibody (Clone: 134013, Ig Class: rat IgG2A) was purchased from
R&D System, Inc. All secondary antibodies used for Western blot
were purchased from Calbiochem. AG490 (a JAK2 inhibitor) was
obtained from Calbiochem. STAT3 siRNA, HO-1 siRNA and
control siRNA were purchased from Santa Cruz. The CXCL10
promoter-luciferase construct was obtained as a generous gift from
Narayan Bhat (Department of Neuroscience, Medical University of
South Carolina, Charleston, SC). Hemin, CoPP and ZnPP were
purchased from Frontier Scientific (Logan, UT).
Measurement of parasitemia and hemoglobin (Hb)
Parasitaemia and anemia status were monitored daily by thin
blood smears of tail blood and were tested for eight consecutive
days. Parasitemia was determined by counting the number of
pRBC in a total count of 1000 RBC in thin blood smears fixed by
methanol and stained by Giemsa (Sigma, St. Louis, MO). Anemia
was evaluated by counting the Hb by HESKA CBC Diff
Veterinary Hematology System.
Quantification of Heme
Plasma was centrifuged for 5 min at 4uC at 1100 g to remove
contaminating red blood cells and were passed through a Microcon
YM-3 column (Millipore) for 60 min at 14uC at 21,000 g to remove
proteins (MW.3 kDa). Free Heme was quantified in protein-
depleted plasma using a chromogenic assay according to the
manufacturer’s instructions (BioAssay System, Hayward, CA).
Enzyme immunoassay (EIA)
EIA was performed using mouse HO-1 immunoset kit from
Assay Designs (Ann Arbor, MI). A 96-well-plate (Nunc, Roskillde,
Denmark) was coated with 100–200 ng of mouse HO-1 capture
antibody in phosphate buffered solution (PBS) and allowed to
incubate overnight at 4uC. The plates were then blocked by
addition of 1% bovine serum albumin (BSA) in PBS for at least
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0.1% Tween-20 in PBS, recombinant HO-1 standard and samples
were loaded into the wells in triplicate incubating at room
temperature for 1 hour. After 3 times of washing, HO-1 detection
antibody was made in PBS with 1% BSA and added into each well
and incubated at 37uC for 1 hours. Anti-mouse immunoglobulin
(Assay Designs, Ann Arbor, MI) conjugated to horseradish
peroxidase (HRP) was incubated in wells and colorimetric
development was performed by addition of the HRP substrate.
Absorbance was read at 450 nm.
Western blotting
Animal tissues were homogenized and incubated for 60 min at
4uC in lysis buffer, samples were separated by SDS/PAGE, and
separated proteins were transferred to nitrocellulose membranes
and identified by immunoblotting. Primary antibodies were
obtained from commercial sources, these antibodies were diluted
at the ratio of 1:1000 according to manufacture’s instruction, while
secondary antibodies included HRP-conjugated anti-rabbit and
anti-mouse antibodies were obtained from Calbiochem. Blots were
developed with Supersignal Pico or Femto substrate (Pierce). A
densitomeric analysis of the bands were performed with the
ImageQuant program (Bio-Rad).
Immunohistochemistry (IHC) and Immunofluorescence
staining
Animal organs were removed after intracardial perfusion with
PBS, sectioned (5 mm) and stained for H&E. Sections were
deparaffinized with xylene followed by rehydration through a
graded series of ethanol and double distilled water in a standard
manner. Specific primary antibodies were added at 1:200 dilution
overnight. The sections were then incubated with biotinylated
secondary antibodies (1:200, Vector, Burlingame, CA, USA) for
60 min at RT, the avidin-biotin complex (ABC Kit, Vector,
Burlingame, CA, USA) for 30 min. For TUNEL assay, the in situ
cell death detection kit (TMR red; Boehringer-Mannheim,
Mannheim, Germany) were used. The sections were incubated
with the TUNEL reaction solution for 60 min at 37uC in the dark.
For labeling of endothelial cells with vWF antibody, sections
were incubated with a rabbit polyclonal anti-vWF antibody (1:250,
DAKO, Carpinteria, CA) for 60 min at 37uC. The sections were
then incubated with biotinylated goat anti-rabbit IgG (1:200,
Vector, Burlingame, CA), and in avidin-biotin complex (ABC Kit)
for 30 min. Fluorescein staining was developed using the Alexa-
488 fluorescence system (Molecular Probes, Carlsbad, CA).
Fluorescent images was collected by using a Zeiss LSM510
confocal microscope and images were captured with LSM
software version 2.3 (Carl Zeiss, Wetzlar, Germany).
Real-time RT-PCR analysis
Animal tissues or cell pellets were stored in Trizol reagent and
homogenized in fresh Trizol. Total RNA were isolated from cells
using an RNeasy Mini Kit (Qiagen, Valencia, CA). cDNA were
synthesized from the isolated RNA using iScript cDNA Synthesis
Kit (Bio-Rad Laboratories, Inc.). Reverse transcription was
performed by using random hexamers at 25uC for 5 minutes,
42uC for 30 minutes, and 85uC for 5 minutes. Quantitative PCR
were performed using iQ SYBR Green Supermix (Bio-Rad
Laboratories, Inc.) in a CFX96 Real-Time PCR System machine
(Bio-Rad Laboratories, Inc.). The data was analyzed using CFX96
Real-Time PCR System (Bio-Rad Laboratories, Inc.). Primer
sequences for the mouse HO-1, CXCL10 and GAPDH genes were
described in Table 1.
Luciferase reporter gene assay
CRL-2581 cells were transfected using lipofectamine 2000
(Invitrogen) with 0.75 mg of CXCL10 promoter-luciferase con-
struct together with 100 mg of pRL-TK, a cytomegalovirus-Renilla
vector to control transfection efficiency. The amount of total DNA
transfected was equalized with the appropriate amounts of control
vectors. After transfection at different indicated points, cells were
harvested and lysed in reporter lysis buffer (Promega, Madison,
WI). Luciferase activity was determined by using the Dual
Luciferase Kit (Promega) and a luminometer (Turner Design,
Sunnyvale, CA) according to the manufacturer’s recommendation.
All luciferase results were normalized to Renilla activity from the
co-transfected pRL-TK plasmid. The data for luciferase activity
was expressed as fold induction with respect to control cells and
was the mean 6 standard error of triplicate samples.
Statistical analysis
The results obtained in this work were from triplicate
experiments performed independently by identical methods. EIA
data and densitometeric measurements from Western blot analyses
in mice were log-transformed to normalize the distribution for
infected (n=6) and control (n=6) samples. Data were expressed as
the mean 6 standard error of mean (SEM). Data from the P.
berghei ANKA infected and control groups were compared. The p
values were determined by using nonparametric Mann-Whitney
U-test. A value of p,0.05 was considered statistically significant.
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